Literature DB >> 32155465

Down-regulated microRNA-195-5p and up-regulated CXCR4 attenuates the heart function injury of heart failure mice via inactivating JAK/STAT pathway.

Yuhua Shen1, Wen Zhang1, Lijun Lee2, Mianming Hong2, Minfei Lee2, Guohui Chou2, Li Yu2, Yuqing Sui2, Baihua Chou3.   

Abstract

OBJECTIVE: Little is known regarding the functional role of microRNA-195-5p (miR-195-5p) in heart failure (HF). Hence, the aim of the present study was to investigate the effect of miR-195-5p on cardiac function in mice with HF and its mechanism through the regulation of Chemokine receptor type 4 (CXCR4) and Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway.
METHODS: The mice model of HF was established by transverse aortic constriction, the successfully modeled mice were injected with anti-miR-195-5p and OE-CXCR4. The expression of miR-195-5p, CXCR4, JAK2 and STAT1 in the myocardial tissues of each group were detected. The target relationship between miR-195-5p and CXCR4 was verified. The indices of cardiac ultrasound, hemodynamics, oxidative stress, inflammatory factor, myocardial enzyme and cardiac function were detected.
RESULTS: MiR-195-5p, JAK2 and STAT1 expression were raised and CXCR4 expression was degraded in myocardial tissues of HF mice and CXCR4 was the target gene of miR-195-5p. Down-regulated miR-195-5p and up-regulated CXCR4 ameliorated cardiac function, abated inflammatory factors contents, oxidative stress reaction and myocardial enzyme indices in HF mice. Down-regulated miR-195-5p and up-regulated CXCR4 suppressed apoptosis of cardiomyocytes in HF mice.
CONCLUSION: Depleting miR-195-5p and up-regulating CXCR4 alleviates cardiac function injury in mice with HF via inhibition of JAK/STAT signaling pathway activation. MiR-195-5p might be a potential candidate marker and therapeutic target for HF.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  CXCR4; Cardiomyocyte; Heart failure; Heart function; JAK/STAT pathway; MicroRNA-195-5p

Year:  2020        PMID: 32155465     DOI: 10.1016/j.intimp.2020.106225

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  3 in total

1.  MiR-181c protects cardiomyocyte injury by preventing cell apoptosis through PI3K/Akt signaling pathway.

Authors:  Xiaoli Li; Jiuchang Zhong; Zhen Zeng; Hongjiang Wang; Jing Li; Xiaoyan Liu; Xinchun Yang
Journal:  Cardiovasc Diagn Ther       Date:  2020-08

2.  Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction.

Authors:  Bo Liang; Yi Liang; Ning Gu
Journal:  BMC Cardiovasc Disord       Date:  2022-06-10       Impact factor: 2.174

Review 3.  A narrative review of the roles of the miR-15/107 family in heart disease: lessons and prospects for heart disease.

Authors:  Manni Zheng; Min Wang
Journal:  Ann Transl Med       Date:  2021-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.